Page
%P
-
Article
Open AccessEarly combination therapy of COVID-19 in high-risk patients
Prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been observed in immunocompromised hosts. Early monotherapy with direct-acting antivirals or monoclonal antibodies, as rec...
-
Article
Open AccessAntiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation?
-
Article
Open AccessTecovirimat for the treatment of severe Mpox in Germany
In May 2022, a multi-national mpox outbreak was reported in several non-endemic countries. The only licensed treatment for mpox in the European Union is the orally available small molecule tecovirimat, which in O...
-
Article
Open AccessSevere monkeypox-virus infection in undiagnosed advanced HIV infection
-
Article
Open AccessSARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness